Hagerstown Location
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PI, Hagerstown Site
ALTITUDE, NCT04567550: RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

Recruiting
2
130
US
ABBV-RGX-314 Dose 1, Genetic/ Combination Product, ABBV-RGX-314 Dose 2, ABBV-RGX-314 Dose 3, Topical Steroid, ABBV-RGX-314 Dose 4, Aflibercept
AbbVie, REGENXBIO Inc.
Diabetic Retinopathy (DR), Center-Involved Diabetic Macular Edema (CI-DME)
02/26
09/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PI, Hagerstown Site
ALTITUDE, NCT04567550: RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

Recruiting
2
130
US
ABBV-RGX-314 Dose 1, Genetic/ Combination Product, ABBV-RGX-314 Dose 2, ABBV-RGX-314 Dose 3, Topical Steroid, ABBV-RGX-314 Dose 4, Aflibercept
AbbVie, REGENXBIO Inc.
Diabetic Retinopathy (DR), Center-Involved Diabetic Macular Edema (CI-DME)
02/26
09/26

Download Options